E9(R1) Statistical Principles for Clinical Trials: Addendum: Estimands and Sensitivity Analysis in Clinical Trials: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 11, 2021
May 11, 2021
e136fe4a-71f3-4725-890a-e85d5d6c6414
Related Documents
Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products
Guidance DocumentMay 26, 2023Center for Drug Evaluation and Research
Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Annex
Guidance DocumentMay 11, 2021Center for Drug Evaluation and Research
S5(R3) Detection of Reproductive and Developmental Toxicity for Human Pharmaceuticals : Guidance for Industry
Guidance DocumentMay 11, 2021Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.